Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
IN8BIO, INC. See All Filings	D	2025-12-30 16:22:27 UTC
Amount To Be Raised $40,239,043 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001740279 Filed Document 0001231919-25-000676 Exclusions or Exemptions 506b Accepted Date 2025-12-30 16:22:27 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
IN8BIO, INC. See All Filings	D	2024-10-15 16:04:24 UTC
Amount To Be Raised $12,379,983 Associated Brokers / Dealers Newbridge Securities Corporation CIK Number 0001740279 Filed Document 0001231919-24-000084 Exclusions or Exemptions 506c Accepted Date 2024-10-15 16:04:24 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
IN8BIO, INC. See All Filings	D	2023-12-28 12:28:18 UTC
Amount To Be Raised $14,425,013 Associated Brokers / Dealers Cantor Fitzgerald & Co. CIK Number 0001740279 Filed Document 0001231919-23-000076 Exclusions or Exemptions 506b Accepted Date 2023-12-28 12:28:18 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
IN8BIO, INC. See All Filings	D/A	2020-09-04 15:10:06 UTC
Amount To Be Raised $34,980,581 Associated Brokers / Dealers N/A CIK Number 0001740279 Filed Document 0001740279-20-000003 Exclusions or Exemptions 506b Accepted Date 2020-09-04 15:10:06 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Incysus Therapeutics, Inc. See All Filings	D/A	2018-09-20 16:05:26 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers N/A CIK Number 0001740279 Filed Document 0001740279-18-000002 Exclusions or Exemptions 506b Accepted Date 2018-09-20 16:05:26 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Incysus Therapeutics, Inc. See All Filings	D	2018-05-22 16:00:55 UTC
Amount To Be Raised $8,000,000 Associated Brokers / Dealers N/A CIK Number 0001740279 Filed Document 0001740279-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-05-22 16:00:55 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity